Clinical trial • Phase I • Oncology
ABBV-CLS-484 for Metastatic or locally advanced tumours | Advanced cancer
Phase I trial of ABBV-CLS-484 for Metastatic or locally advanced tumours | Advanced cancer. 98 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Metastatic or locally advanced tumours | Advanced cancer
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 29-12-2023
- First CTIS Authorization Date
- 11-03-2024
Trial design
Phase I trial across 8 sites in France, Spain.
- Target Sample Size
- 98
Recruitment
- Planned Sample Size
- 98
- Recruitment Window Months
- 62
Geography
- Total Number Of Sites
- 8
- Total Number Of Participants
- 200
France
- Earliest CTIS Part Ii Submission Date
- 03-09-2023
- Latest Decision Or Authorization Date
- 15-09-2025
- Processing Time Days
- 743
- Number Of Sites
- 5
- Number Of Participants
- 100
Sites
- Site Name
- Hospital Foch
- Contact Person Name
- Jaafar Bennouna
- Contact Person Email
- j.bennouna@hopital-foch.com
- Site Name
- Institut De Cancerologie De L Ouest
- Department Name
- Medical oncology
- Contact Person Name
- Judith Raimbourg
- Contact Person Email
- judith.raimbourg@ico.unicancer.fr
- Site Name
- Institut Universitaire Du Cancer Toulouse-Oncopole
- Contact Person Name
- Iphigenie Korakis
- Contact Person Email
- korakis.iphigenie@iuct-oncopole.fr
- Site Name
- Centre Antoine Lacassagne
- Contact Person Name
- Esma Saada-Bouzid
- Contact Person Email
- esma.saada-bouzid@nice.unicancer.fr
- Site Name
- Institut Paoli-Calmettes
- Contact Person Name
- Cecile Vicier
- Contact Person Email
- vicierc@ipc.unicancer.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 03-09-2023
- Latest Decision Or Authorization Date
- 29-09-2025
- Processing Time Days
- 757
- Number Of Sites
- 3
- Number Of Participants
- 100
Sites
- Site Name
- Hospital Universitario Hm Sanchinarro
- Contact Person Name
- Emiliano Calvo Aller
- Contact Person Email
- emiliano.calvo@startmadrid.com
- Site Name
- Institut Catala D'oncologia
- Department Name
- Unidad de Fase 1
- Contact Person Name
- Marta Gil Martin
- Contact Person Email
- mgilmartin@iconcologia.net
- Site Name
- Hospital Universitario 12 De Octubre
- Contact Person Name
- Jon Zugazagoitia Fraile
- Contact Person Email
- j.zugazagoitia.imas12@h12o.es
Sponsor
Primary sponsor
- Full Name
- Calico Life Sciences LLC
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- ABBV-CLS-484
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)